Accusations of impropriety feature in escalating dispute.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Jinek, M. et al. Science 337, 816–821 (2012).
Cong, L. et al. Science 339, 819–823 (2013).
Related links
Related links
Related links in Nature Research
Chinese scientists to pioneer first human CRISPR trial 2016-Jul-21
The unsung heroes of CRISPR 2016-Jul-20
First CRISPR clinical trial gets green light from US panel 2016-Jun-22
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. Titanic clash over CRISPR patents turns ugly. Nature 537, 460–461 (2016). https://doi.org/10.1038/537460a
Published:
Issue date:
DOI: https://doi.org/10.1038/537460a
This article is cited by
-
TILLING by Sequencing (TbyS) for targeted genome mutagenesis in crops
Molecular Breeding (2017)
